Highlights the limitations and potential adverse effects of current diagnostic modalities for myocardial ischemia in patients with chronic kidney disease.
Current diagnostics for ischemia in CKD warrant caution; leaves open development of more accurate, safer modalities.
Coronary artery disease is the leading cause of mortality and morbidity in the chronic kidney disease (CKD) population and often presents with atypical symptoms. Current diagnostic investigations of myocardial ischemia in CKD lack sensitivity and specificity or may have adverse effects. We present a case vignette and explore the challenges of diagnostic myocardial stress investigation in patients with CKD.
No takes yet. Share an insight, caveat, or question.
Parnham et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: